Analysts project orforglipron sales could reach significant figures in the coming decade, with retatrutide generating substantial revenue in the same timeframe [3]
If you or a loved one suffered severe complications after taking Ozempic, Wegovy, Mounjaro, Zepbound, Rybelsus, or another GLP-1 medication, contact TorHoerman Law for a free case review to learn more about your legal options
Appetite and sleep changes Self-reported appetite shifts (in both directions) and altered sleep difficulty falling asleep, lighter sleep, or vivid dreams are described inconsistently across community sources, with no documented dose relationship
You may not be a candidate for NAD therapy if you: Have specific medical conditions, like kidney disease or certain sensitivities Are pregnant or breastfeeding Are unaware of the side effects of NAD If you are curious about NAD and whether it could be right for you, contact our team
is employed by Lantana Bio